A new study shows that a shingles vaccine may also slow down biological ageing among older adults, along with protecting ...

After accounting for demographic and health differences, those who had received the shingles vaccine exhibited signs of ...

Sanofi's acquisition of Dynavax, valued at $2.2 billion, aims to enhance its vaccine portfolio, including a promising shingles vaccine candidate, Z-1018. Z-1018 has demonstrated comparable ...

The researchers believe this is likely a measurement issue rather than a health risk. The vaccine creates memory T-cells to ...

A study showed people 70 or older who had the shingles jab scored better on four key aspects of biological aging.

Shingles vaccination not only protects against the disease but may also contribute to slower biological aging in older adults, according to a new USC Leonard Davis School of Gerontology study.

Shingles vaccination not only protects against the disease but may also contribute to slower biological aging in older adults ...

Addressing India’s vaccination gap for older adults is crucial for improving public health and preventing severe infections.

The risk of shingles jumps 11-fold after the first dose of the recombinant shingles vaccine, marketed under the name name Shingrix, but decreases by 73% after the second, according to the results of a ...

Multiple studies show the common vaccine offers unexpected brain protection, prompting scientists to investigate the ...

GSK plc (NYSE:GSK) is one of the best performing pharma stocks in 2025. Jefferies reaffirmed a Buy rating on GSK plc ...